This SuperSeries is composed of the SubSeries listed below.
Overall design: Refer to individual Series
| Accession | PRJNA887022; GEO: GSE214757 |
| Type | Umbrella project |
| Publications | Helminen L et al., "Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer.", Nucleic Acids Res, 2024 Jan 25;52(2):625-642 |
| Submission | Registration date: 4-Oct-2022
Biomedicine, School of Medicine, University of Eastern Finland |
| Relevance | Superseries |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 195 |
| Publications |
| PubMed | 1 |
| PMC | 1 |
| Other datasets |
| BioSample | 195 |
| GEO DataSets | 4 |
Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer encompasses the following 3 sub-projects:
| Project Type | Number of Projects |
| Epigenomics | 2 |
BioProject
accession | Organism | Title |
|---|
| PRJNA887026 | Homo sapiens | Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer (ChIP-Seq) (Biomedicine, School of Medicine,...) | | PRJNA887027 | Homo sapiens | Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer (ATAC-Seq) (Biomedicine, School of Medicine,...) |
|
| Transcriptome or Gene expression | 1 |
BioProject
accession | Organism | Title |
|---|
| PRJNA887025 | Homo sapiens | Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer (RNA-Seq) (Biomedicine, School of Medicine,...) |
|